Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?

BACKGROUND: The ACTION trial was initiated to provide evidence from a randomised trial on the effects of chemotherapy in women aged over 70 years where evidence for risk and benefit are lacking. METHODS: This was a randomised, phase III clinical trial for high risk, oestrogen receptor (ER) negative/...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard, R, Ballinger, R, Cameron, D, Ellis, P, Fallowfield, L, Gosney, M, Johnson, L, Kilburn, L S, Makris, A, Mansi, J, Reed, M, Ring, A, Robinson, A, Simmonds, P, Thomas, G, Bliss, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241551/
https://www.ncbi.nlm.nih.gov/pubmed/21989185
http://dx.doi.org/10.1038/bjc.2011.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241551/
https://www.ncbi.nlm.nih.gov/pubmed/21989185
http://dx.doi.org/10.1038/bjc.2011.377

Ejemplares similares